REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual drug therapy for the treatment of symptomatic benign prostatic hyperplasia refractory to alpha-blocker monotherapy in sexually active men.
Epistemonikos ID: 87de2fe492d4779f7269fce167ab1dc1657bd25d
First added on: May 08, 2024